Application of Chinese violet in resisting diabetes mellitus and preventing relative metabolic diseases

A technology for metabolic diseases, Radix Viola

Inactive Publication Date: 2009-12-16
INST OF MATERIA MEDICA AN INST OF THE CHINESE ACAD OF MEDICAL SCI
View PDF0 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The main side effects of this class

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Chinese violet in resisting diabetes mellitus and preventing relative metabolic diseases
  • Application of Chinese violet in resisting diabetes mellitus and preventing relative metabolic diseases
  • Application of Chinese violet in resisting diabetes mellitus and preventing relative metabolic diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] Example 1. Preparation of Viola Viola Extract

[0048] 1kg of dried Viola dichotoma was extracted twice with 10 times the amount of water, 2 hours each time, the combined extract was placed at room temperature, the extract was passed through the treated macroporous resin column, eluted with water, and then eluted with 30% ethanol. The eluate was concentrated under reduced pressure to obtain 30 g of the effective fraction.

[0049] Pharmacological experiment

experiment example 1

[0050] Experimental Example 1. Effect of Viola Didin Extract on Blood Glucose Levels in Type 1 Diabetic Mice

[0051] method:

[0052] Normal male ICR mice, weighing 24-26g, were injected with 70mg / kg of alloxan into the tail vein. Blood glucose levels were measured by the glucose oxidase method. Animals whose blood glucose level exceeded 200 mg / dl after 72 hours were selected as type 1 diabetes model mice.

[0053] 30 diabetic mice were randomly divided into 4 groups according to the blood sugar level: the control group, metformin, viola 1 and viola 2 groups, and the same volume of water, metformin 200mg / kg, viola 1g / kg (equivalent to crude drug 4.5g / kg) and violadin 2g / kg (equivalent to crude drug 9.1g / kg) for intragastric administration. After administration for 9 consecutive days, the animal's blood glucose (equivalent to postprandial blood glucose) in the morning (8:30am) and blood glucose (equivalent to fasting blood glucose) after fasting for 2 hours were measured. ...

experiment example 2

[0056] Experimental Example 2. Effect of Viola Didin Extract on Oral Glucose Tolerance in Type 1 Diabetic Mice

[0057] method:

[0058] Normal male ICR mice, weighing 24-26g, were injected with 70mg / kg of alloxan into the tail vein. Blood glucose levels were measured by the glucose oxidase method. Animals whose blood glucose level exceeded 200 mg / dl after 72 hours were selected as type 1 diabetes model mice.

[0059] 30 diabetic mice were randomly divided into 4 groups according to the blood sugar level: the control group, metformin, viola 1 and viola 2 groups, and the same volume of water, metformin 200mg / kg, viola 1g / kg (equivalent to crude drug 4.5g / kg) and violadin 2g / kg (equivalent to crude drug 9.1g / kg) for intragastric administration. Continuous administration for 14 days. Glucose 2g / kg was administered to the animals, and the blood glucose levels were measured at 0, 30, 60, and 120 minutes after the glucose load, and the area under the blood glucose-time curve (A...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses application of Chinese violet in resisting diabetes mellitus and preventing relative metabolic diseases, in particular extract and effective parts of viola yedoensis makino, a preparation method of the extract and the effective parts, a medicine composition containing the extract or effective parts of the Chinese violet, and application of products for preventing diabetes mellitus and relative metabolic diseases.

Description

technical field [0001] The present invention relates to Viola Yedoensis Makino extract and effective parts; preparation method of the extract and effective parts; pharmaceutical composition containing Viola Yedoensis Makino extract or effective parts; The use of metabolic disease products belongs to the technical field of medicine. Background technique [0002] Diabetes is a chronic metabolic disease characterized by elevated blood sugar, mainly divided into insulin-dependent type 1 diabetes and non-insulin-dependent type 2 diabetes. Impaired glucose tolerance refers to the body's reduced tolerance to glucose. Insulin resistance refers to the reduced sensitivity and / or responsiveness of the body to insulin, which is the common pathophysiological basis of diabetes-related metabolic diseases, and is related to impaired glucose tolerance / type 2 diabetes and its complications, obesity, Clinical abnormalities such as dyslipidemia, non-alcoholic fatty liver disease, and coronary...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/86A23L1/29A61P3/10A23L33/00
Inventor 叶菲张东明田金英吴倩杨敬芝丛维娜刘倩陶荣亚牛亚景左丽
Owner INST OF MATERIA MEDICA AN INST OF THE CHINESE ACAD OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products